How AstraZeneca Raised Inversion Concerns With Washington to Help Fend Off ...

Wall Street JournalHow AstraZeneca Raised Inversion Concerns With Washington to Help Fend Off ...Wall Street JournalWithin a matter of weeks this summer, the Obama administration went from being a mostly passive objector to the architect of still-undisclosed policies aimed at curtailing the tax benefits of such deals. Administration officials described a crescendo ...